公司资料
Ionis Pharmaceuticals, Inc. 股价、新闻与催化剂
- 股票代码:
- IONS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
46.75 USD (+4.26%)
收盘价
最后更新: 2026年9月17日
12.1B USD
市值
股价为何变动
截至 2026年9月17日，IONS 上涨 4.26%，收于 $46.75。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Ionis Pharmaceuticals is an antisense-RNA company with one of the deepest RNA-targeting pipelines in biotech.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, it sits in specialty biotechnology with global partnered reach.
商业模式特征
The company combines commercial products, royalties, milestones, and a pipeline of partnered and internally developed RNA programs.
生物医药行业定位
Ionis is a premier RNA-platform name, and its stock tends to react to clinical data, partnership economics, and label expansion.
未来催化剂
- Ionis’s catalysts are olezarsen commercialization, donidalorsen / neurology progress, and broader RNA-targeting pipeline validation. The next update will help show whether the company is moving from promise to a more de-risked stage of execution. Investors will care less about the label than about whether the platform can keep producing credible next steps.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。